semaglutide and anorexia I don't speak about my previous eating disorders much anymore - I have come on leaps bounds since then GLP-1 medications are changing the

Nausea and vomiting are the most reported, with rates peaking early in treatment

These benefits may complement ALAs antioxidant and nerve-supporting effects, making ALCAR a potential co-therapy for those looking to take a multi-pronged approach.63 ALCAR is generally well tolerated, though side effects like agitation, dry mouth, or insomnia may occur in sensitive individuals

23 Eating past this point can lead to significant discomfort and worsen side effects like nausea or vomiting

Many are using a range of strategies to ensure appropriate use, including validating clinical eligibility with biometric data, requiring participation in a Even so, while more than half of employers covering GLP-1s for weight management expect the drugs to deliver meaningful clinical benefits, few say those gains have yet shown up in aggregate claims data, such as lower obesity rates or reduced need for bariatric surgery, according to the survey

Dapagliflozin reduced renal expression of Bax, renal tubule injury and TUNEL-positive cells and increased renal expression of hypoxia-inducible factor 1 to protect kidney [22]